Rafael Holdings, Inc.
RFLRafael Holdings is a biotechnology company focused on developing pharmaceuticals and medical devices for rare diseases and oncology.
Earnings
Next report
Date not yet announcedValuation & ratios
Segments
By product
Competitors
By market cap
By revenue growth
By net margin
Profile
Rafael Holdings is a biotechnology company focused on developing pharmaceuticals and medical devices for rare diseases and oncology. The company's primary value proposition is the clinical advancement of its lead drug candidate, Trappsol® Cyclo™, for the treatment of Niemann-Pick Disease Type C1. Additionally, the firm manages a diverse portfolio of majority-owned subsidiaries specializing in cancer metabolism, orthopedic surgical instruments, and bioavailability technologies.
A clinical-stage developer focused on orphan drug designations and niche orthopedic markets, transitioning from a real estate holding company to a pure-play biotech entity.
Questions, answered.
- What is Rafael Holdings, Inc.'s market cap?
- Rafael Holdings, Inc. (RFL) has a market capitalization of $118.0M and trades on NYSE.
- What is Rafael Holdings, Inc.'s revenue and profitability?
- Rafael Holdings, Inc. generated $980.0K in trailing twelve-month revenue with a net loss of $20.7M, representing a net margin of -2117.2%. Gross margin stands at 71.9%, with free cash flow of -$23.2M. These figures are based on the Q2 2026 filing.
- Who are Rafael Holdings, Inc.'s competitors?
- Rafael Holdings, Inc.'s key competitors include Johnson & Johnson, Zevra Therapeutics, Intel, and others. These companies compete in similar markets and product categories.
- Who does Rafael Holdings, Inc. partner with?
- Rafael Holdings, Inc.'s notable partners include Princeton University, Ludwig Institute for Cancer Research, Yissum Research and Development Company, and others.
- What subsidiaries does Rafael Holdings, Inc. have?
- Rafael Holdings, Inc.'s subsidiaries include Cyclo Therapeutics, LLC, LipoMedix Pharmaceuticals Ltd., Cornerstone Pharmaceuticals, Inc., and others.
- Where is Rafael Holdings, Inc. headquartered?
- Rafael Holdings, Inc. is headquartered in United States of America and employs approximately 13 people. It has been publicly traded since 2018.
